Evidence map›Paper›PMID 40313500›Full record

ArticleFrontiers in public health2025

Recent trends in cosmic radiation exposure onboard aircraft: effects of the COVID-19 pandemic on Japanese in-flight doses.

Hiroshi Yasuda, Hiroto Motoyama, Kazuaki Yajima

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hiroshi YasudaResearch Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Hiroto MotoyamaSchool of Medicine, Hiroshima University, Hiroshima, Japan.
Kazuaki YajimaNational Institutes for Quantum Science and Technology, Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Galactic cosmic radiation (GCR) is a naturally occurring environmental radiation that originates from outer space. GCR is modulated by solar activity, and its intensity increases with increasing geomagnetic latitude and altitude, reaching a peak of up to approximately 20 km in the atmosphere. Therefore, commercial flight passengers (flyers) are exposed to elevated levels of cosmic radiation while flying onboard commercial aircraft. Although the recent COVID-19 pandemic, which began in early 2020, is believed to have significantly affected public exposure to cosmic radiation, this impact is yet to be quantified. Methods: Based on the official records of Japanese flyers, their annual per-capita doses (APCDs) of cosmic radiation exposure on international and domestic flights were calculated using the established code JISCARD EX over a 7-year period from 2014 to 2020 (including the first year of the pandemic). For estimating the APCDs on international flights, the world was divided into eight regions. The aviation route dose to a representative city in each region was determined at three cruising altitudes: 34,000 ft. (10.4 km), 37,000 ft. (11.3 km), and 40,000 ft. (12.2 km). Results: At a typical cruising altitude of 37,000 ft., the flyer-average APCD from international flights was estimated to be approximately 60 μSv y Conclusion: The results of this study indicate that the population-average APCD of Japanese flyers decreased significantly during the COVID-19 pandemic, while the flyer-average APCD remained largely unchanged. Further studies will be performed to determine APCDs for the subsequent period and to assess the overall effect of the pandemic on public health.

Indexed as

AircraftCosmic RadiationCOVID-19Radiation ExposureHumansJapanPandemicsSARS-CoV-2aviation dosecommercial flightcosmic radiationCOVID-19 pandemicJapaneseper-capita

Identifiers

PMID40313500
PMCPMC12043470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.